Par, UCB Pharma Settle Keppra Patent Fight
UCB Pharma SA and Par Pharmaceutical Inc. on Monday settled a suit Par had filed in Pennsylvania seeking a court declaration that two UCB patents were invalid and not infringed by...To view the full article, register now.
Already a subscriber? Click here to view full article